Injecting Special Protein Could Make Hearts Heal Themselves

80beats
By Allison Bond
Jul 28, 2009 12:54 AMNov 5, 2019 8:58 PM
heartanatomyweb.jpg

Newsletter

Sign up for our email newsletter for the latest science news
 

Injecting a certain protein into mice and rats stimulated their heart cells to multiply after a heart attack, improving cardiac function. The experiment's results point to a possible method to regenerate damaged human heart tissue, according to a study published in the journal Cell. The adult heart is remarkably static. Although research this year revealed that a tiny number of new heart muscle cells are created in adulthood, that cellular regeneration tapers off throughout life, so heart damage inflicted during a heart attack does not heal naturally. But scientists found that injecting a growth factor called neuregulin1 (NRG1) into mice and rats stimulated the animals' heart cells to divide. After 12 weeks of daily injections, the animals' hearts showed less hypertrophy, or enlargement, and improved function. For instance, the hearts had about a 10 percent increase in ejection fraction--the fraction of blood pumped out of the left ventricle with each beat. The treatment "didn't make the damage go away completely, ... but it did make the heart work significantly better" [

0 free articles left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

0 free articlesSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!

Subscribe

Already a subscriber?

Register or Log In

Stay Curious

Sign up for our weekly newsletter and unlock one more article for free.

 

View our Privacy Policy


Want more?
Keep reading for as low as $1.99!


Log In or Register

Already a subscriber?
Find my Subscription

More From Discover
Recommendations From Our Store
Stay Curious
Join
Our List

Sign up for our weekly science updates.

 
Subscribe
To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2024 Kalmbach Media Co.